[New recognition of a role of dyslipidemia and lipid-lowering treatment in pathogenesis of renal disease].
作者信息
Li Xue-wang, Li Hang
出版信息
Zhonghua Nei Ke Za Zhi. 2004 Dec;43(12):881-2.
PMID:15730728
Abstract
摘要
相似文献
1
[New recognition of a role of dyslipidemia and lipid-lowering treatment in pathogenesis of renal disease].[对血脂异常及降脂治疗在肾脏疾病发病机制中作用的新认识]
Zhonghua Nei Ke Za Zhi. 2004 Dec;43(12):881-2.
2
Hyperlipidemia and its management in renal disease.肾病中的高脂血症及其管理
Curr Opin Nephrol Hypertens. 1996 Mar;5(2):141-6. doi: 10.1097/00041552-199603000-00007.
3
The pharmacological treatment of dyslipidemia.血脂异常的药物治疗。
Annu Rev Pharmacol Toxicol. 1989;29:265-88. doi: 10.1146/annurev.pa.29.040189.001405.
4
[Effect of lipid-lowering by tonifying kidney].补肾降脂的作用
Zhong Xi Yi Jie He Za Zhi. 1991 Jan;11(1):25-7.
5
[Treatments for dyslipidemia associated with kidney disease].[与肾脏疾病相关的血脂异常的治疗方法]
Nihon Rinsho. 2001 Mar;59 Suppl 3:748-52.
6
One great leap for lipid lowering drugs.降脂药物的一大飞跃。
Cardiovasc J S Afr. 2002 Sep-Oct;13(5):265-6.
7
Niacin as a component of combination therapy for dyslipidemia.烟酸作为血脂异常联合治疗的一种成分。
Mayo Clin Proc. 2003 Jun;78(6):735-42. doi: 10.4065/78.6.735.
8
[Dyslipidemia in renal failure].[肾衰竭中的血脂异常]
Nihon Rinsho. 2004 Jun;62 Suppl 6:118-23.
9
Treating dyslipidemia to slow the progression of chronic renal failure.治疗血脂异常以延缓慢性肾衰竭的进展。
Am J Med. 2003 Apr 1;114(5):411-2. doi: 10.1016/s0002-9343(03)00070-6.
10
[Ischemic heart diseases and lipid metabolism: a circulation specialist's viewpoint].[缺血性心脏病与脂质代谢：一位循环系统专家的观点]
Nihon Naika Gakkai Zasshi. 2001 Oct 10;90(10):2093-9.
Zotero 插件